Intracoronary cardiac progenitor cells in single ventricle physiology: the perseus (cardiac progenitor cell infusion to treat univentricular heart disease) randomized phase 2 trial

Circulation Research

Volumn 120, Issue 7, 2017, Pages 1162-1173

  Ishigami, Shuta ^a   Ohtsuki, Shinichi ^a   Eitoku, Takahiro ^a   Ousaka, Daiki ^a   Kondo, Maiko ^a   Kurita, Yoshihiko ^a   Hirai, Kenta ^a   Fukushima, Yosuke ^a   Baba, Kenji ^a   Goto, Takuya ^a   Horio, Naohiro ^a   Kobayashi, Junko ^a   Kuroko, Yosuke ^a   Kotani, Yasuhiro ^a   Arai, Sadahiko ^a   Iwasaki, Tatsuo ^a   Sato, Shuhei ^a   Kasahara, Shingo ^a   Sano, Shunji ^a   Oh, Hidemasa ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

cell therapy; heart disease; heart failure; hypoplastic left heart syndrome; stem cell

Indexed keywords

AMIODARONE; SCATTER FACTOR; SOMATOMEDIN C;

ARTICLE; BODY GROWTH; CARDIAC STEM CELL; CELL THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HEART PROARRHYTHMIA; HEART SINGLE VENTRICLE; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; MALE; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; CARDIAC MUSCLE CELL; CLINICAL TRIAL; CORONARY BLOOD VESSEL; CYTOLOGY; INFANT; INTRAARTERIAL DRUG ADMINISTRATION; MYOBLAST; PRESCHOOL CHILD; PROCEDURES; STEM CELL TRANSPLANTATION; THERAPY; TRANSPLANTATION;

CHILD, PRESCHOOL; CORONARY VESSELS; FEMALE; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; MALE; MYOBLASTS; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; VENTRICULAR DYSFUNCTION;

EID: 85009178481     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.310253     Document Type: Article

References (34)

1. Triedman JK, Newburger JW, Trends in congenital heart disease: the next decade. Circulation 2016 133 2716 2733. doi: 10.1161/CIRCULATIONAHA.116.023544.
2. Newburger JW, Sleeper LA, Frommelt PC, Pediatric Heart Network Investigators Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation 2014 129 2013 2020. doi: 10.1161/CIRCULATIONAHA.113.006191.
3. Stout KK, Broberg CS, Book WM, American Heart Association Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Cardiovascular Radiology and Imaging Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation 2016 133 770 801. doi: 10.1161/CIR.0000000000000352.
4. Ross HJ, Law Y, Book WM, American Heart Association Adults With Congenital Heart Disease Committee of the Council on Clinical Cardiology and Council on Cardiovascular Disease in the Young, the Council on Cardiovascular Radiology and Intervention, and the Council on Functional Genomics and Translational Biology Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the American Heart Association. Circulation 2016 133 802 820. doi: 10.1161/CIR.0000000000000353.
5. Gurvitz M, Burns KM, Brindis R, Emerging research directions in adult congenital heart disease: a report from an NHLBI/ACHA Working Group. J Am Coll Cardiol 2016 67 1956 1964. doi: 10.1016/j.jacc.2016.01.062.
6. Ohye RG, Schranz D, D'Udekem Y, Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 2016 134 1265 1279. doi: 10.1161/CIRCULATIONAHA.116.022816.
7. Oh H, Ito H, Sano S, Challenges to success in heart failure: cardiac cell therapies in patients with heart diseases. J Cardiol 2016 68 361 367. doi: 10.1016/j.jjcc.2016.04.010.
8. Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T, Takahashi T, Takamatsu T, Fukushima M, Komeda M, Yamagishi M, Yaku H, Tabata Y, Matsubara H, Oh H, Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 2008 52 1858 1865. doi: 10.1016/j.jacc.2008.06.052.
9. Nguyen PK, Rhee JW, Wu JC, Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol 2016 1 831 841. doi: 10.1001/jamacardio.2016.2225.
10. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012 379 895 904. doi: 10.1016/S0140-6736(12)60195-0.
11. Bergmann O, Zdunek S, Felker A, Dynamics of Cell Generation and Turnover in the Human Heart. Cell 2015 161 1566 1575. doi: 10.1016/j.cell.2015.05.026.
12. Ishigami S, Ohtsuki S, Tarui S, Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res 2015 116 653 664. doi: 10.1161/CIRCRESAHA.116.304671.
13. Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, Oh H, Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg 2015 150 1198 1207, 1208.e1. doi: 10.1016/j.jtcvs.2015.06.076.
14. Rathod RH, Prakash A, Powell AJ, Geva T, Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol 2010 55 1721 1728. doi: 10.1016/j.jacc.2009.12.036.
15. Dipchand AI, Kirk R, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Lund LH, Rahmel AO, Yusen RD, Stehlik J, International Society for Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report-2013; focus theme: age. J Heart Lung Transplant 2013 32 979 988. doi: 10.1016/j.healun.2013.08.005.
16. Dubin AM, Janousek J, Rhee E, Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005 46 2277 2283. doi: 10.1016/j.jacc.2005.05.096.
17. Chetan D, Kotani Y, Jacques F, Poynter JA, Benson LN, Lee KJ, Chaturvedi RR, Friedberg MK, Van Arsdell GS, Caldarone CA, Honjo O, Surgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants. Circulation 2013 128 S205 S212. doi: 10.1161/CIRCULATIONAHA.112.000380.
18. Baldwin JT, Borovetz HS, Duncan BW, Gartner MJ, Jarvik RK, Weiss WJ, The national heart, lung, and blood institute pediatric circulatory support program: a summary of the 5-year experience. Circulation 2011 123 1233 1240. doi: 10.1161/CIRCULATIONAHA.110.978023.
19. Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, Silberstein LE, Dos Remedios CG, Graham D, Colan S, Kühn B, Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 2013 110 1446 1451. doi: 10.1073/pnas.1214608110.
20. Kotani Y, Kasahara S, Fujii Y, Eitoku T, Baba K, Otsuki S, Kuroko Y, Arai S, Sano S, A staged decompression of right ventricle allows growth of right ventricle and subsequent biventricular repair in patients with pulmonary atresia and intact ventricular septum. Eur J Cardiothorac Surg 2016 50 298 303. doi: 10.1093/ejcts/ezw124.
21. Hsu DT, Zak V, Mahony L, Pediatric Heart Network Investigators Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 2010 122 333 340. doi: 10.1161/CIRCULATIONAHA.109.927988.
22. Anderson PA, Sleeper LA, Mahony L, Pediatric Heart Network Investigators Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008 52 85 98. doi: 10.1016/j.jacc.2008.01.074.
23. Rathod RH, Prakash A, Kim YY, Germanakis IE, Powell AJ, Gauvreau K, Geva T, Cardiac magnetic resonance parameters predict transplantation-free survival in patients with fontan circulation. Circ Cardiovasc Imaging 2014 7 502 509. doi: 10.1161/CIRCIMAGING.113.001473.
24. Malliaras K, Smith RR, Kanazawa H, Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation 2013 128 2764 2775. doi: 10.1161/CIRCULATIONAHA.113.002863.
25. Weil BR, Suzuki G, Leiker MM, Fallavollita JA, Canty JM Jr, Comparative efficacy of intracoronary allogeneic mesenchymal stem cells and cardiosphere-derived cells in swine with hibernating myocardium. Circ Res 2015 117 634 644. doi: 10.1161/CIRCRESAHA.115.306850.
26. Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, Marban L, Ghaleh B, Marban E, Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J 2016 pii ehw240
27. Hare JM, Fishman JE, Gerstenblith G, Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012 308 2369 2379. doi: 10.1001/jama.2012.25321.
28. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E, Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012 59 942 953. doi: 10.1016/j.jacc.2011.11.029.
29. Avitabile CM, Leonard MB, Brodsky JL, Whitehead KK, Ravishankar C, Cohen MS, Gaynor JW, Rychik J, Goldberg DJ, Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure. Am J Cardiol 2015 115 816 820. doi: 10.1016/j.amjcard.2014.12.041.
30. Pérez-Calvo JI, Morales-Rull JL, Gimeno-Orna JA, Lasierra-Díaz P, Josa-Laorden C, Puente-Lanzarote JJ, Bettencourt P, Pascual-Figal DA, Usefulness of the hepatocyte growth factor as a predictor of mortality in patients hospitalized with acute heart failure regardless of ejection fraction. Am J Cardiol 2016 118 543 549. doi: 10.1016/j.amjcard.2016.05.048.
31. Boucek RJ Jr, Steele J, Jacobs JP, Steele P, Asante-Korang A, Quintessenza J, Steele A, Ex vivo paracrine properties of cardiac tissue: Effects of chronic heart failure. J Heart Lung Transplant 2015 34 839 848. doi: 10.1016/j.healun.2014.07.010.
32. Newburger JW, Sleeper LA, Bellinger DC, Pediatric Heart Network Investigators Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation 2012 125 2081 2091. doi: 10.1161/CIRCULATIONAHA.111.064113.
33. McCrindle BW, Zak V, Sleeper LA, Paridon SM, Colan SD, Geva T, Mahony L, Li JS, Breitbart RE, Margossian R, Williams RV, Gersony WM, Atz AM, Pediatric Heart Network Investigators Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation 2010 121 34 42. doi: 10.1161/CIRCULATIONAHA.109.869396.
34. Burch PT, Gerstenberger E, Ravishankar C, Pediatric Heart Network Investigators Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc 2014 3 e000079. doi: 10.1161/JAHA.114.000079.